AVEO AVEO Pharmaceuticals 8-K2021AVEO Oncology Highlights Recent Progress and 2021 Outlook
12 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
AVEO 8-K Filings
- 12 Jan 21 AVEO Oncology Highlights Recent Progress and 2021 Outlook
- 9 Nov 20 AVEO Oncology Reports Third Quarter 2020 Financial Results and Provides Business Update
- 8 Sep 20 Announces Decision to Fund Clinical Manufacture of Ficlatuzumab
- 10 Aug 20 AVEO Oncology Reports Second Quarter 2020 Financial Results and Provides Business Update
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…